Did Inclusion of informed consent affect the observed hiv prevalence rate among injecting drug users during hiv sentinel surveillance 2017 in Delhi, Uttar Pradesh, Uttarakhand, and Jharkhand States of Central Zone of India?
Background: In 2017, the sampling procedure for HIV sentinel surveillance (HSS) among all high-risk groups was changed from the consecutive sampling to random sampling along with the introduction of linked anonymous testing strategy with informed written consent. Objective: The objective of this stu...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2020-01-01
|
| Series: | Indian Journal of Public Health |
| Subjects: | |
| Online Access: | http://www.ijph.in/article.asp?issn=0019-557X;year=2020;volume=64;issue=5;spage=67;epage=70;aulast=Rai |
| _version_ | 1818155544261689344 |
|---|---|
| author | Sanjay Kumar Rai Farhad Ahamed Shashi Kant Partha Haldar Shreya Jha Shobini Rajan |
| author_facet | Sanjay Kumar Rai Farhad Ahamed Shashi Kant Partha Haldar Shreya Jha Shobini Rajan |
| author_sort | Sanjay Kumar Rai |
| collection | DOAJ |
| description | Background: In 2017, the sampling procedure for HIV sentinel surveillance (HSS) among all high-risk groups was changed from the consecutive sampling to random sampling along with the introduction of linked anonymous testing strategy with informed written consent. Objective: The objective of this study was to assess whether the inclusion of informed consent affects the HIV positivity rate among the participants and nonparticipants injecting drug users (IDU) in HSS 2017 in four states of Central Zone of India. Methods: This study was a cross-sectional study. All sentinel sites from Delhi, Uttar Pradesh, Jharkhand, and Uttarakhand located at targeted intervention facilities in 2017 were included in the study. Information about the participation and nonparticipation of each high-risk individual at the sentinel site was gathered from the master list, respective registers, and website portal of the National AIDS Control Organization. A total of 8639 individuals were included in the analysis. Results: Overall, 16 sites in four states were included in the study. Overall, the nonparticipation rate of IDUs was 14.3%; highest being for Delhi (17.2%), followed by Uttar Pradesh (14.6%), Uttarakhand (10.9%), and Jharkhand (4.4%). Overall, the HIV-positivity rate among nonparticipants (9.6%) was significantly higher (P = 0.009) compared to the participants (6.7%). Conclusion: Change in methodology and seeking written informed consent might have an effect on the nonparticipation in all four states. This, in turn, could have led to the underestimation of HIV-positivity rates among IDU in the states. |
| first_indexed | 2024-12-11T14:44:05Z |
| format | Article |
| id | doaj.art-c4ce01193409448db9e2f39e0281b886 |
| institution | Directory Open Access Journal |
| issn | 0019-557X |
| language | English |
| last_indexed | 2024-12-11T14:44:05Z |
| publishDate | 2020-01-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | Indian Journal of Public Health |
| spelling | doaj.art-c4ce01193409448db9e2f39e0281b8862022-12-22T01:01:47ZengWolters Kluwer Medknow PublicationsIndian Journal of Public Health0019-557X2020-01-01645677010.4103/ijph.IJPH_35_20Did Inclusion of informed consent affect the observed hiv prevalence rate among injecting drug users during hiv sentinel surveillance 2017 in Delhi, Uttar Pradesh, Uttarakhand, and Jharkhand States of Central Zone of India?Sanjay Kumar RaiFarhad AhamedShashi KantPartha HaldarShreya JhaShobini RajanBackground: In 2017, the sampling procedure for HIV sentinel surveillance (HSS) among all high-risk groups was changed from the consecutive sampling to random sampling along with the introduction of linked anonymous testing strategy with informed written consent. Objective: The objective of this study was to assess whether the inclusion of informed consent affects the HIV positivity rate among the participants and nonparticipants injecting drug users (IDU) in HSS 2017 in four states of Central Zone of India. Methods: This study was a cross-sectional study. All sentinel sites from Delhi, Uttar Pradesh, Jharkhand, and Uttarakhand located at targeted intervention facilities in 2017 were included in the study. Information about the participation and nonparticipation of each high-risk individual at the sentinel site was gathered from the master list, respective registers, and website portal of the National AIDS Control Organization. A total of 8639 individuals were included in the analysis. Results: Overall, 16 sites in four states were included in the study. Overall, the nonparticipation rate of IDUs was 14.3%; highest being for Delhi (17.2%), followed by Uttar Pradesh (14.6%), Uttarakhand (10.9%), and Jharkhand (4.4%). Overall, the HIV-positivity rate among nonparticipants (9.6%) was significantly higher (P = 0.009) compared to the participants (6.7%). Conclusion: Change in methodology and seeking written informed consent might have an effect on the nonparticipation in all four states. This, in turn, could have led to the underestimation of HIV-positivity rates among IDU in the states.http://www.ijph.in/article.asp?issn=0019-557X;year=2020;volume=64;issue=5;spage=67;epage=70;aulast=Raihiv prevalencehiv sentinel surveillanceinjecting drug users |
| spellingShingle | Sanjay Kumar Rai Farhad Ahamed Shashi Kant Partha Haldar Shreya Jha Shobini Rajan Did Inclusion of informed consent affect the observed hiv prevalence rate among injecting drug users during hiv sentinel surveillance 2017 in Delhi, Uttar Pradesh, Uttarakhand, and Jharkhand States of Central Zone of India? Indian Journal of Public Health hiv prevalence hiv sentinel surveillance injecting drug users |
| title | Did Inclusion of informed consent affect the observed hiv prevalence rate among injecting drug users during hiv sentinel surveillance 2017 in Delhi, Uttar Pradesh, Uttarakhand, and Jharkhand States of Central Zone of India? |
| title_full | Did Inclusion of informed consent affect the observed hiv prevalence rate among injecting drug users during hiv sentinel surveillance 2017 in Delhi, Uttar Pradesh, Uttarakhand, and Jharkhand States of Central Zone of India? |
| title_fullStr | Did Inclusion of informed consent affect the observed hiv prevalence rate among injecting drug users during hiv sentinel surveillance 2017 in Delhi, Uttar Pradesh, Uttarakhand, and Jharkhand States of Central Zone of India? |
| title_full_unstemmed | Did Inclusion of informed consent affect the observed hiv prevalence rate among injecting drug users during hiv sentinel surveillance 2017 in Delhi, Uttar Pradesh, Uttarakhand, and Jharkhand States of Central Zone of India? |
| title_short | Did Inclusion of informed consent affect the observed hiv prevalence rate among injecting drug users during hiv sentinel surveillance 2017 in Delhi, Uttar Pradesh, Uttarakhand, and Jharkhand States of Central Zone of India? |
| title_sort | did inclusion of informed consent affect the observed hiv prevalence rate among injecting drug users during hiv sentinel surveillance 2017 in delhi uttar pradesh uttarakhand and jharkhand states of central zone of india |
| topic | hiv prevalence hiv sentinel surveillance injecting drug users |
| url | http://www.ijph.in/article.asp?issn=0019-557X;year=2020;volume=64;issue=5;spage=67;epage=70;aulast=Rai |
| work_keys_str_mv | AT sanjaykumarrai didinclusionofinformedconsentaffecttheobservedhivprevalencerateamonginjectingdrugusersduringhivsentinelsurveillance2017indelhiuttarpradeshuttarakhandandjharkhandstatesofcentralzoneofindia AT farhadahamed didinclusionofinformedconsentaffecttheobservedhivprevalencerateamonginjectingdrugusersduringhivsentinelsurveillance2017indelhiuttarpradeshuttarakhandandjharkhandstatesofcentralzoneofindia AT shashikant didinclusionofinformedconsentaffecttheobservedhivprevalencerateamonginjectingdrugusersduringhivsentinelsurveillance2017indelhiuttarpradeshuttarakhandandjharkhandstatesofcentralzoneofindia AT parthahaldar didinclusionofinformedconsentaffecttheobservedhivprevalencerateamonginjectingdrugusersduringhivsentinelsurveillance2017indelhiuttarpradeshuttarakhandandjharkhandstatesofcentralzoneofindia AT shreyajha didinclusionofinformedconsentaffecttheobservedhivprevalencerateamonginjectingdrugusersduringhivsentinelsurveillance2017indelhiuttarpradeshuttarakhandandjharkhandstatesofcentralzoneofindia AT shobinirajan didinclusionofinformedconsentaffecttheobservedhivprevalencerateamonginjectingdrugusersduringhivsentinelsurveillance2017indelhiuttarpradeshuttarakhandandjharkhandstatesofcentralzoneofindia |